BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1076140, encodeId=d0cb10e6140f3, content=请问这个提交后需要所有作者确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0d95459478, createdName=詹妮弗, createdTime=Thu Dec 02 10:08:33 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074560, encodeId=a73d10e456011, content=请问大家需要WB的完整图片吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c542458439, createdName=124105aem18暂无昵称, createdTime=Sat Nov 27 18:02:21 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074297, encodeId=987710e429787, content=请问投稿模板没找到的话，就按照作者指南的要求写就行了吗？还是按照已经发表的格式写啊，完全一头雾水。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ac25618971, createdName=ms1000001711095909, createdTime=Fri Nov 26 17:54:05 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071029, encodeId=fe1110e102959, content=想问一下大家，收药剂学方面的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af3c5597406, createdName=ms2000001168385813, createdTime=Wed Nov 17 10:27:44 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067295, encodeId=3f94106e29585, content=杂志上显示3天接收的文章，会这么快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a8a5315883, createdName=148999f2m69暂无昵称, createdTime=Fri Nov 05 15:00:23 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055160, encodeId=473c105516022, content=偏重的研究方向：肿瘤 经验分享：投稿8天了，还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d7e2868906, createdName=282597582, createdTime=Sun Sep 26 21:42:24 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054793, encodeId=7c9c1054e93a5, content=这个投稿有格式要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc905472554, createdName=龚huping, createdTime=Sat Sep 25 21:27:08 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015672, encodeId=aa1810156e2dc, content=这个杂志是按照稿号顺序审的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a85e5091452, createdName=145d4029m98暂无昵称, createdTime=Wed Sep 08 12:55:32 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015008, encodeId=6b841015008b8, content=偏重的研究方向：肿瘤 经验分享：请问这个杂志收protocol吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd395586243, createdName=ms6000000773534819, createdTime=Mon Sep 06 11:44:04 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004283, encodeId=70a0100428385, content=偏重的研究方向：免疫 ; 免疫学 ; microRNA 经验分享：没有做WB，有免疫组化实验结果可以不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Sat Jul 31 21:27:57 CST 2021, time=2021-07-31, status=1, ipAttribution=)]

2021-12-02 詹妮弗

请问这个提交后需要所有作者确认吗

28 0

[GetPortalCommentsPageByObjectIdResponse(id=1076140, encodeId=d0cb10e6140f3, content=请问这个提交后需要所有作者确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0d95459478, createdName=詹妮弗, createdTime=Thu Dec 02 10:08:33 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074560, encodeId=a73d10e456011, content=请问大家需要WB的完整图片吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c542458439, createdName=124105aem18暂无昵称, createdTime=Sat Nov 27 18:02:21 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074297, encodeId=987710e429787, content=请问投稿模板没找到的话，就按照作者指南的要求写就行了吗？还是按照已经发表的格式写啊，完全一头雾水。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ac25618971, createdName=ms1000001711095909, createdTime=Fri Nov 26 17:54:05 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071029, encodeId=fe1110e102959, content=想问一下大家，收药剂学方面的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af3c5597406, createdName=ms2000001168385813, createdTime=Wed Nov 17 10:27:44 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067295, encodeId=3f94106e29585, content=杂志上显示3天接收的文章，会这么快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a8a5315883, createdName=148999f2m69暂无昵称, createdTime=Fri Nov 05 15:00:23 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055160, encodeId=473c105516022, content=偏重的研究方向：肿瘤 经验分享：投稿8天了，还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d7e2868906, createdName=282597582, createdTime=Sun Sep 26 21:42:24 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054793, encodeId=7c9c1054e93a5, content=这个投稿有格式要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc905472554, createdName=龚huping, createdTime=Sat Sep 25 21:27:08 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015672, encodeId=aa1810156e2dc, content=这个杂志是按照稿号顺序审的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a85e5091452, createdName=145d4029m98暂无昵称, createdTime=Wed Sep 08 12:55:32 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015008, encodeId=6b841015008b8, content=偏重的研究方向：肿瘤 经验分享：请问这个杂志收protocol吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd395586243, createdName=ms6000000773534819, createdTime=Mon Sep 06 11:44:04 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004283, encodeId=70a0100428385, content=偏重的研究方向：免疫 ; 免疫学 ; microRNA 经验分享：没有做WB，有免疫组化实验结果可以不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Sat Jul 31 21:27:57 CST 2021, time=2021-07-31, status=1, ipAttribution=)]

2021-11-27 124105aem18暂无昵称

请问大家需要WB的完整图片吗

39 0

[GetPortalCommentsPageByObjectIdResponse(id=1076140, encodeId=d0cb10e6140f3, content=请问这个提交后需要所有作者确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0d95459478, createdName=詹妮弗, createdTime=Thu Dec 02 10:08:33 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074560, encodeId=a73d10e456011, content=请问大家需要WB的完整图片吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c542458439, createdName=124105aem18暂无昵称, createdTime=Sat Nov 27 18:02:21 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074297, encodeId=987710e429787, content=请问投稿模板没找到的话，就按照作者指南的要求写就行了吗？还是按照已经发表的格式写啊，完全一头雾水。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ac25618971, createdName=ms1000001711095909, createdTime=Fri Nov 26 17:54:05 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071029, encodeId=fe1110e102959, content=想问一下大家，收药剂学方面的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af3c5597406, createdName=ms2000001168385813, createdTime=Wed Nov 17 10:27:44 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067295, encodeId=3f94106e29585, content=杂志上显示3天接收的文章，会这么快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a8a5315883, createdName=148999f2m69暂无昵称, createdTime=Fri Nov 05 15:00:23 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055160, encodeId=473c105516022, content=偏重的研究方向：肿瘤 经验分享：投稿8天了，还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d7e2868906, createdName=282597582, createdTime=Sun Sep 26 21:42:24 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054793, encodeId=7c9c1054e93a5, content=这个投稿有格式要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc905472554, createdName=龚huping, createdTime=Sat Sep 25 21:27:08 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015672, encodeId=aa1810156e2dc, content=这个杂志是按照稿号顺序审的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a85e5091452, createdName=145d4029m98暂无昵称, createdTime=Wed Sep 08 12:55:32 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015008, encodeId=6b841015008b8, content=偏重的研究方向：肿瘤 经验分享：请问这个杂志收protocol吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd395586243, createdName=ms6000000773534819, createdTime=Mon Sep 06 11:44:04 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004283, encodeId=70a0100428385, content=偏重的研究方向：免疫 ; 免疫学 ; microRNA 经验分享：没有做WB，有免疫组化实验结果可以不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Sat Jul 31 21:27:57 CST 2021, time=2021-07-31, status=1, ipAttribution=)]

2021-11-26 ms1000001711095909

请问投稿模板没找到的话，就按照作者指南的要求写就行了吗？还是按照已经发表的格式写啊，完全一头雾水。

27 0

[GetPortalCommentsPageByObjectIdResponse(id=1076140, encodeId=d0cb10e6140f3, content=请问这个提交后需要所有作者确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0d95459478, createdName=詹妮弗, createdTime=Thu Dec 02 10:08:33 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074560, encodeId=a73d10e456011, content=请问大家需要WB的完整图片吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c542458439, createdName=124105aem18暂无昵称, createdTime=Sat Nov 27 18:02:21 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074297, encodeId=987710e429787, content=请问投稿模板没找到的话，就按照作者指南的要求写就行了吗？还是按照已经发表的格式写啊，完全一头雾水。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ac25618971, createdName=ms1000001711095909, createdTime=Fri Nov 26 17:54:05 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071029, encodeId=fe1110e102959, content=想问一下大家，收药剂学方面的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af3c5597406, createdName=ms2000001168385813, createdTime=Wed Nov 17 10:27:44 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067295, encodeId=3f94106e29585, content=杂志上显示3天接收的文章，会这么快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a8a5315883, createdName=148999f2m69暂无昵称, createdTime=Fri Nov 05 15:00:23 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055160, encodeId=473c105516022, content=偏重的研究方向：肿瘤 经验分享：投稿8天了，还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d7e2868906, createdName=282597582, createdTime=Sun Sep 26 21:42:24 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054793, encodeId=7c9c1054e93a5, content=这个投稿有格式要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc905472554, createdName=龚huping, createdTime=Sat Sep 25 21:27:08 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015672, encodeId=aa1810156e2dc, content=这个杂志是按照稿号顺序审的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a85e5091452, createdName=145d4029m98暂无昵称, createdTime=Wed Sep 08 12:55:32 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015008, encodeId=6b841015008b8, content=偏重的研究方向：肿瘤 经验分享：请问这个杂志收protocol吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd395586243, createdName=ms6000000773534819, createdTime=Mon Sep 06 11:44:04 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004283, encodeId=70a0100428385, content=偏重的研究方向：免疫 ; 免疫学 ; microRNA 经验分享：没有做WB，有免疫组化实验结果可以不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Sat Jul 31 21:27:57 CST 2021, time=2021-07-31, status=1, ipAttribution=)]

2021-11-17 ms2000001168385813

想问一下大家，收药剂学方面的文章吗

36 0

[GetPortalCommentsPageByObjectIdResponse(id=1076140, encodeId=d0cb10e6140f3, content=请问这个提交后需要所有作者确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0d95459478, createdName=詹妮弗, createdTime=Thu Dec 02 10:08:33 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074560, encodeId=a73d10e456011, content=请问大家需要WB的完整图片吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c542458439, createdName=124105aem18暂无昵称, createdTime=Sat Nov 27 18:02:21 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074297, encodeId=987710e429787, content=请问投稿模板没找到的话，就按照作者指南的要求写就行了吗？还是按照已经发表的格式写啊，完全一头雾水。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ac25618971, createdName=ms1000001711095909, createdTime=Fri Nov 26 17:54:05 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071029, encodeId=fe1110e102959, content=想问一下大家，收药剂学方面的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af3c5597406, createdName=ms2000001168385813, createdTime=Wed Nov 17 10:27:44 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067295, encodeId=3f94106e29585, content=杂志上显示3天接收的文章，会这么快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a8a5315883, createdName=148999f2m69暂无昵称, createdTime=Fri Nov 05 15:00:23 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055160, encodeId=473c105516022, content=偏重的研究方向：肿瘤 经验分享：投稿8天了，还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d7e2868906, createdName=282597582, createdTime=Sun Sep 26 21:42:24 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054793, encodeId=7c9c1054e93a5, content=这个投稿有格式要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc905472554, createdName=龚huping, createdTime=Sat Sep 25 21:27:08 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015672, encodeId=aa1810156e2dc, content=这个杂志是按照稿号顺序审的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a85e5091452, createdName=145d4029m98暂无昵称, createdTime=Wed Sep 08 12:55:32 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015008, encodeId=6b841015008b8, content=偏重的研究方向：肿瘤 经验分享：请问这个杂志收protocol吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd395586243, createdName=ms6000000773534819, createdTime=Mon Sep 06 11:44:04 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004283, encodeId=70a0100428385, content=偏重的研究方向：免疫 ; 免疫学 ; microRNA 经验分享：没有做WB，有免疫组化实验结果可以不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Sat Jul 31 21:27:57 CST 2021, time=2021-07-31, status=1, ipAttribution=)]

2021-11-05 148999f2m69暂无昵称

杂志上显示3天接收的文章，会这么快吗

60 0

[GetPortalCommentsPageByObjectIdResponse(id=1076140, encodeId=d0cb10e6140f3, content=请问这个提交后需要所有作者确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0d95459478, createdName=詹妮弗, createdTime=Thu Dec 02 10:08:33 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074560, encodeId=a73d10e456011, content=请问大家需要WB的完整图片吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c542458439, createdName=124105aem18暂无昵称, createdTime=Sat Nov 27 18:02:21 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074297, encodeId=987710e429787, content=请问投稿模板没找到的话，就按照作者指南的要求写就行了吗？还是按照已经发表的格式写啊，完全一头雾水。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ac25618971, createdName=ms1000001711095909, createdTime=Fri Nov 26 17:54:05 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071029, encodeId=fe1110e102959, content=想问一下大家，收药剂学方面的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af3c5597406, createdName=ms2000001168385813, createdTime=Wed Nov 17 10:27:44 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067295, encodeId=3f94106e29585, content=杂志上显示3天接收的文章，会这么快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a8a5315883, createdName=148999f2m69暂无昵称, createdTime=Fri Nov 05 15:00:23 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055160, encodeId=473c105516022, content=偏重的研究方向：肿瘤 经验分享：投稿8天了，还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d7e2868906, createdName=282597582, createdTime=Sun Sep 26 21:42:24 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054793, encodeId=7c9c1054e93a5, content=这个投稿有格式要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc905472554, createdName=龚huping, createdTime=Sat Sep 25 21:27:08 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015672, encodeId=aa1810156e2dc, content=这个杂志是按照稿号顺序审的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a85e5091452, createdName=145d4029m98暂无昵称, createdTime=Wed Sep 08 12:55:32 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015008, encodeId=6b841015008b8, content=偏重的研究方向：肿瘤 经验分享：请问这个杂志收protocol吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd395586243, createdName=ms6000000773534819, createdTime=Mon Sep 06 11:44:04 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004283, encodeId=70a0100428385, content=偏重的研究方向：免疫 ; 免疫学 ; microRNA 经验分享：没有做WB，有免疫组化实验结果可以不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Sat Jul 31 21:27:57 CST 2021, time=2021-07-31, status=1, ipAttribution=)]

2021-09-26 282597582

偏重的研究方向：肿瘤
经验分享：投稿8天了，还是with editor

32 0

[GetPortalCommentsPageByObjectIdResponse(id=1076140, encodeId=d0cb10e6140f3, content=请问这个提交后需要所有作者确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0d95459478, createdName=詹妮弗, createdTime=Thu Dec 02 10:08:33 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074560, encodeId=a73d10e456011, content=请问大家需要WB的完整图片吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c542458439, createdName=124105aem18暂无昵称, createdTime=Sat Nov 27 18:02:21 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074297, encodeId=987710e429787, content=请问投稿模板没找到的话，就按照作者指南的要求写就行了吗？还是按照已经发表的格式写啊，完全一头雾水。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ac25618971, createdName=ms1000001711095909, createdTime=Fri Nov 26 17:54:05 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071029, encodeId=fe1110e102959, content=想问一下大家，收药剂学方面的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af3c5597406, createdName=ms2000001168385813, createdTime=Wed Nov 17 10:27:44 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067295, encodeId=3f94106e29585, content=杂志上显示3天接收的文章，会这么快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a8a5315883, createdName=148999f2m69暂无昵称, createdTime=Fri Nov 05 15:00:23 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055160, encodeId=473c105516022, content=偏重的研究方向：肿瘤 经验分享：投稿8天了，还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d7e2868906, createdName=282597582, createdTime=Sun Sep 26 21:42:24 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054793, encodeId=7c9c1054e93a5, content=这个投稿有格式要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc905472554, createdName=龚huping, createdTime=Sat Sep 25 21:27:08 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015672, encodeId=aa1810156e2dc, content=这个杂志是按照稿号顺序审的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a85e5091452, createdName=145d4029m98暂无昵称, createdTime=Wed Sep 08 12:55:32 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015008, encodeId=6b841015008b8, content=偏重的研究方向：肿瘤 经验分享：请问这个杂志收protocol吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd395586243, createdName=ms6000000773534819, createdTime=Mon Sep 06 11:44:04 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004283, encodeId=70a0100428385, content=偏重的研究方向：免疫 ; 免疫学 ; microRNA 经验分享：没有做WB，有免疫组化实验结果可以不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Sat Jul 31 21:27:57 CST 2021, time=2021-07-31, status=1, ipAttribution=)]

2021-09-25 龚huping

这个投稿有格式要求吗？

26 0

[GetPortalCommentsPageByObjectIdResponse(id=1076140, encodeId=d0cb10e6140f3, content=请问这个提交后需要所有作者确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0d95459478, createdName=詹妮弗, createdTime=Thu Dec 02 10:08:33 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074560, encodeId=a73d10e456011, content=请问大家需要WB的完整图片吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c542458439, createdName=124105aem18暂无昵称, createdTime=Sat Nov 27 18:02:21 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074297, encodeId=987710e429787, content=请问投稿模板没找到的话，就按照作者指南的要求写就行了吗？还是按照已经发表的格式写啊，完全一头雾水。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ac25618971, createdName=ms1000001711095909, createdTime=Fri Nov 26 17:54:05 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071029, encodeId=fe1110e102959, content=想问一下大家，收药剂学方面的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af3c5597406, createdName=ms2000001168385813, createdTime=Wed Nov 17 10:27:44 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067295, encodeId=3f94106e29585, content=杂志上显示3天接收的文章，会这么快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a8a5315883, createdName=148999f2m69暂无昵称, createdTime=Fri Nov 05 15:00:23 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055160, encodeId=473c105516022, content=偏重的研究方向：肿瘤 经验分享：投稿8天了，还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d7e2868906, createdName=282597582, createdTime=Sun Sep 26 21:42:24 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054793, encodeId=7c9c1054e93a5, content=这个投稿有格式要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc905472554, createdName=龚huping, createdTime=Sat Sep 25 21:27:08 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015672, encodeId=aa1810156e2dc, content=这个杂志是按照稿号顺序审的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a85e5091452, createdName=145d4029m98暂无昵称, createdTime=Wed Sep 08 12:55:32 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015008, encodeId=6b841015008b8, content=偏重的研究方向：肿瘤 经验分享：请问这个杂志收protocol吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd395586243, createdName=ms6000000773534819, createdTime=Mon Sep 06 11:44:04 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004283, encodeId=70a0100428385, content=偏重的研究方向：免疫 ; 免疫学 ; microRNA 经验分享：没有做WB，有免疫组化实验结果可以不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Sat Jul 31 21:27:57 CST 2021, time=2021-07-31, status=1, ipAttribution=)]

2021-09-08 145d4029m98暂无昵称

这个杂志是按照稿号顺序审的吗？

29 0

[GetPortalCommentsPageByObjectIdResponse(id=1076140, encodeId=d0cb10e6140f3, content=请问这个提交后需要所有作者确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0d95459478, createdName=詹妮弗, createdTime=Thu Dec 02 10:08:33 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074560, encodeId=a73d10e456011, content=请问大家需要WB的完整图片吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c542458439, createdName=124105aem18暂无昵称, createdTime=Sat Nov 27 18:02:21 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074297, encodeId=987710e429787, content=请问投稿模板没找到的话，就按照作者指南的要求写就行了吗？还是按照已经发表的格式写啊，完全一头雾水。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ac25618971, createdName=ms1000001711095909, createdTime=Fri Nov 26 17:54:05 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071029, encodeId=fe1110e102959, content=想问一下大家，收药剂学方面的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af3c5597406, createdName=ms2000001168385813, createdTime=Wed Nov 17 10:27:44 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067295, encodeId=3f94106e29585, content=杂志上显示3天接收的文章，会这么快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a8a5315883, createdName=148999f2m69暂无昵称, createdTime=Fri Nov 05 15:00:23 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055160, encodeId=473c105516022, content=偏重的研究方向：肿瘤 经验分享：投稿8天了，还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d7e2868906, createdName=282597582, createdTime=Sun Sep 26 21:42:24 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054793, encodeId=7c9c1054e93a5, content=这个投稿有格式要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc905472554, createdName=龚huping, createdTime=Sat Sep 25 21:27:08 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015672, encodeId=aa1810156e2dc, content=这个杂志是按照稿号顺序审的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a85e5091452, createdName=145d4029m98暂无昵称, createdTime=Wed Sep 08 12:55:32 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015008, encodeId=6b841015008b8, content=偏重的研究方向：肿瘤 经验分享：请问这个杂志收protocol吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd395586243, createdName=ms6000000773534819, createdTime=Mon Sep 06 11:44:04 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004283, encodeId=70a0100428385, content=偏重的研究方向：免疫 ; 免疫学 ; microRNA 经验分享：没有做WB，有免疫组化实验结果可以不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Sat Jul 31 21:27:57 CST 2021, time=2021-07-31, status=1, ipAttribution=)]

2021-09-06 ms6000000773534819

偏重的研究方向：肿瘤
经验分享：请问这个杂志收protocol吗？

32 0

[GetPortalCommentsPageByObjectIdResponse(id=1076140, encodeId=d0cb10e6140f3, content=请问这个提交后需要所有作者确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0d95459478, createdName=詹妮弗, createdTime=Thu Dec 02 10:08:33 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074560, encodeId=a73d10e456011, content=请问大家需要WB的完整图片吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c542458439, createdName=124105aem18暂无昵称, createdTime=Sat Nov 27 18:02:21 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074297, encodeId=987710e429787, content=请问投稿模板没找到的话，就按照作者指南的要求写就行了吗？还是按照已经发表的格式写啊，完全一头雾水。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ac25618971, createdName=ms1000001711095909, createdTime=Fri Nov 26 17:54:05 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071029, encodeId=fe1110e102959, content=想问一下大家，收药剂学方面的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af3c5597406, createdName=ms2000001168385813, createdTime=Wed Nov 17 10:27:44 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067295, encodeId=3f94106e29585, content=杂志上显示3天接收的文章，会这么快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a8a5315883, createdName=148999f2m69暂无昵称, createdTime=Fri Nov 05 15:00:23 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055160, encodeId=473c105516022, content=偏重的研究方向：肿瘤 经验分享：投稿8天了，还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d7e2868906, createdName=282597582, createdTime=Sun Sep 26 21:42:24 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054793, encodeId=7c9c1054e93a5, content=这个投稿有格式要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc905472554, createdName=龚huping, createdTime=Sat Sep 25 21:27:08 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015672, encodeId=aa1810156e2dc, content=这个杂志是按照稿号顺序审的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a85e5091452, createdName=145d4029m98暂无昵称, createdTime=Wed Sep 08 12:55:32 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015008, encodeId=6b841015008b8, content=偏重的研究方向：肿瘤 经验分享：请问这个杂志收protocol吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd395586243, createdName=ms6000000773534819, createdTime=Mon Sep 06 11:44:04 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004283, encodeId=70a0100428385, content=偏重的研究方向：免疫 ; 免疫学 ; microRNA 经验分享：没有做WB，有免疫组化实验结果可以不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Sat Jul 31 21:27:57 CST 2021, time=2021-07-31, status=1, ipAttribution=)]

2021-07-31 Doctorfan

偏重的研究方向：免疫 ; 免疫学 ; microRNA
经验分享：没有做WB，有免疫组化实验结果可以不？

26 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务